Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Bangkok Post - June 24, 2004
Apiradee Treerutkuarkul
Suboonya Hutangkabodi, deputy secretary-general of the Food and Drug Administration, said health authorities were checking whether any lamivudine and zidovudine tablets had been smuggled into the country.
The move follows WHO reports that the two anti-retroviral drugs, produced by Indian company Cipla Ltd, failed to prove bioequivalence of good clinical practices, good laboratory practices and raw data, despite having received certification for production.
Ms Suboonya said lamivudine was once imported for registration in Thailand, but its registration was revoked after authorities found the drug was similar to the GPOVIR formulation, a cocktail of anti-Aids drugs produced by the Government Pharmaceutical Organisation (GPO).
GPO director Thongchai Tawichachart said the removal of the two drugs from the list would not affect the country's effort to curb the Aids virus because the GPO could produce similar generic drugs with proof of bioequivalence for anti-retroviral treatment.
040624
BP040607
Copyright © 2004 - The Bangkok Post. Reproduction of this article (other than one copy for personal reference) must be cleared through the Bangkok Post.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .